quinpirole has been researched along with Schizophrenia in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (28.57) | 18.2507 |
2000's | 6 (28.57) | 29.6817 |
2010's | 8 (38.10) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Alzheimer, C; Banerjee, A; Bouvier, M; Friedland, K; Gmeiner, P; Hübner, H; Huth, T; Möller, D; Müller, CP; Plouffe, B; Skultety, M; Uzuneser, TC | 1 |
Bhide, PG; Brown, RW; Gill, WD; Peeters, LD | 1 |
Christensen, KV; Christoffersen, CT; Clausen, D; Didriksen, M; Egebjerg, J; Fejgin, K; Kallunki, P; Larsen, PH; Lauridsen, JB; Mørk, A; Nielsen, J; Nielsen, V; Sotty, F; Werge, TM; Yavich, L | 1 |
Brown, RW; Burgess, KC; Cummins, ED; DePreter, CC; Gill, WD; Kirby, SL; Owens, AS; Schlitt, MA | 1 |
Cabungcal, JH; Calhoon, GG; Counotte, DS; Cuenod, M; Do, KQ; Hong, LE; Kil, J; Lewis, E; O'Donnell, P; Piantadosi, P; Pollock, C; Presgraves, E; Sullivan, E; Tejeda, HA | 1 |
Brown, RW; Brus, R; Kostrzewa, RM; Nowak, P | 1 |
Cantrup, R; Rajakumar, N; Rushlow, WJ; Scornaiencki, R | 1 |
Borsini, F; De Carolis, L; Nencini, P; Serlupi-Crescenzi, O; Stasi, MA | 1 |
Brown, RW; Cope, ZA; Kostrzewa, RM; Maple, AM; Perna, MK; Sheppard, AB | 1 |
Lodge, DJ; Perez, SM | 1 |
Noh, HR; Pitcher, L; Shoemaker, JM; Swerdlow, NR | 1 |
Bubser, M; Carraway, RE; Deutch, AY; Fadel, J; Petrie, KA; Schmidt, D | 1 |
Chocyk, A; Fijał, K; Wedzony, K | 1 |
Bermudez-Silva, FJ; Bilbao, A; de Diego, Y; Fernandez-Espejo, E; Ferrer, B; Gornemann, I; Gorriti, MA; Moratalla, R; Navarro, M; Palomino, A; Rodríguez de Fonseca, F | 1 |
Le Moal, M; Louilot, A | 1 |
LeDuc, PA; Mittleman, G; Whishaw, IQ | 1 |
Bristow, LJ; Hutson, PH; Patel, S; Ragan, CI; Seabrook, GR | 1 |
Bergh, CL; Duncan, JN; Harris, DW; Huff, RM; Lahti, RA; Lawson, CF; Lutzke, BS; Martin, IJ; Rees, SA; Schlachter, SK; Sih, JC; Smith, MW; TenBrink, RE | 1 |
Brus, R; Copeland, RL; Kostrzewa, RM; Tizabi, Y | 1 |
Cools, AR; de Bruin, NM; Ellenbroek, BA; Stevens, KE; van Luijtelaar, EL | 1 |
Braff, DL; Geyer, MA; Mansbach, RS; Peng, RY | 1 |
1 review(s) available for quinpirole and Schizophrenia
Article | Year |
---|---|
Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model.
Topics: Animals; Behavior, Addictive; Disease Models, Animal; Nicotine; Quinpirole; Schizophrenia; Tobacco Use Disorder | 2012 |
20 other study(ies) available for quinpirole and Schizophrenia
Article | Year |
---|---|
Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure.
Topics: Animals; Antipsychotic Agents; beta-Arrestins; Dopamine Agonists; Drug Discovery; GTP-Binding Proteins; Humans; Male; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2017 |
The adenosine A(2A) receptor agonist CGS 21680 alleviates auditory sensorimotor gating deficits and increases in accumbal CREB in rats neonatally treated with quinpirole.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Animals, Newborn; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Male; Motor Activity; Nucleus Accumbens; Phenethylamines; Prepulse Inhibition; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Schizophrenia; Sensory Gating | 2020 |
A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.
Topics: Abnormalities, Multiple; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Chromosome Deletion; Chromosomes, Human, Pair 1; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Excitatory Amino Acid Antagonists; Megalencephaly; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Phencyclidine; Phenotype; Prepulse Inhibition; Quinpirole; Receptors, Dopamine; Schizophrenia; Ventral Tegmental Area | 2017 |
Effects of Environmental Enrichment on Nicotine Sensitization in Rats Neonatally Treated with Quinpirole: Analyses of Glial Cell Line-Derived Neurotrophic Factor and Implications towards Schizophrenia.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Dopamine Agonists; Female; Glial Cell Line-Derived Neurotrophic Factor; Housing, Animal; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Quinpirole; Rats; Schizophrenia; Substance-Related Disorders | 2018 |
Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia.
Topics: Acetylcysteine; Animals; Animals, Newborn; Antioxidants; Disease Models, Animal; Dopamine Agonists; Drug Administration Schedule; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Female; Gene Expression Regulation, Developmental; Hippocampus; Ibotenic Acid; In Vitro Techniques; Neurons; Pregnancy; Quinpirole; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2014 |
Perinatal Treatments with the Dopamine D₂-Receptor Agonist Quinpirole Produces Permanent D₂-Receptor Supersensitization: a Model of Schizophrenia.
Topics: Amphetamines; Animals; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Exocytosis; Female; GTP-Binding Proteins; Humans; Locomotion; Male; Quinpirole; Rats; Receptors, Dopamine D2; Schizophrenia; Sex Factors | 2016 |
Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
Topics: Animals; Behavior, Animal; Benzazepines; Desipramine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Infusions, Parenteral; Injections, Intraperitoneal; Locomotion; Male; Nucleus Accumbens; Oxidopamine; Prefrontal Cortex; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; Swimming | 2009 |
The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats.
Topics: Animals; Antipsychotic Agents; Brain; Brain-Derived Neurotrophic Factor; Clozapine; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking; Gene Expression Regulation; Haloperidol; Male; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2010 |
Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia.
Topics: Alkylating Agents; Animals; Behavior, Animal; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Female; Methylazoxymethanol Acetate; Motor Activity; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Dopamine D2; Receptors, Dopamine D4; Schizophrenia; Ventral Tegmental Area | 2012 |
Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus.
Topics: Animals; Antipsychotic Agents; Dibenzothiazepines; Dopamine; Dopamine Agonists; Male; Mediodorsal Thalamic Nucleus; Quetiapine Fumarate; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reflex, Startle; Schizophrenia; Sodium Channel Blockers; Tetrodotoxin | 2002 |
Neurotensin activates GABAergic interneurons in the prefrontal cortex.
Topics: Animals; Axons; Dopamine; Dopamine Agonists; gamma-Aminobutyric Acid; Interneurons; Male; Microdialysis; Neurotensin; Parvalbumins; Prefrontal Cortex; Pyrazoles; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Neurotensin; Schizophrenia; Tetrodotoxin | 2005 |
Blockade of NMDA receptors in postnatal period decreased density of tyrosine hydroxylase immunoreactive axonal arbors in the medial prefrontal cortex of adult rats.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Axons; Excitatory Amino Acid Antagonists; Female; Immunohistochemistry; Motor Activity; Prefrontal Cortex; Pregnancy; Quinpirole; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tyrosine 3-Monooxygenase | 2005 |
Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Piperidines; Pyrazoles; Quinpirole; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rimonabant; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior | 2007 |
Lateralized interdependence between limbicotemporal and ventrostriatal dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Functional Laterality; Hippocampus; Humans; Male; Nucleus Accumbens; Quinpirole; Raclopride; Rats; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Synaptic Transmission; Temporal Lobe; Time Factors | 1994 |
The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Arousal; Brain Mapping; Dextroamphetamine; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Hippocampus; Male; Motor Activity; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior | 1993 |
Functional relevance of dopamine receptors.
Topics: Antipsychotic Agents; Dopamine Agonists; Dopamine Antagonists; Ergolines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Tetrahydronaphthalenes | 1995 |
(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
Topics: Animals; Antipsychotic Agents; Biological Availability; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Humans; Molecular Structure; Piperazines; Protein Binding; Quinpirole; Receptors, Adrenergic; Receptors, Dopamine D4; Receptors, Serotonin; Schizophrenia; Sulfonamides | 1996 |
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications.
Topics: Alkaloids; Animals; Azocines; Behavior, Animal; Bungarotoxins; Dopamine Agonists; Female; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Quinolizines; Quinpirole; Rats; Receptors, Nicotinic; Schizophrenia; Yawning | 1999 |
Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
Topics: Acoustic Stimulation; Animals; Auditory Perception; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electroencephalography; Evoked Potentials, Auditory; Haloperidol; Hippocampus; Male; Neural Inhibition; Neural Pathways; Neurons; Nucleus Accumbens; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Schizophrenia | 2001 |
A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acoustic Stimulation; Animals; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Ergolines; Humans; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 1990 |